Distinct effects of losartan and atenolol on vascular stiffness in Marfan syndrome
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Distinct effects of losartan and atenolol on vascular stiffness in Marfan syndrome
Authors
Keywords
-
Journal
VASCULAR MEDICINE
Volume 20, Issue 4, Pages 317-325
Publisher
SAGE Publications
Online
2015-03-21
DOI
10.1177/1358863x15569868
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Atenolol versus Losartan in Children and Young Adults with Marfan's Syndrome
- (2014) Ronald V. Lacro et al. NEW ENGLAND JOURNAL OF MEDICINE
- Losartan reduces aortic dilatation rate in adults with Marfan syndrome: a randomized controlled trial
- (2013) M. Groenink et al. EUROPEAN HEART JOURNAL
- Effects of renin-angiotensin-aldosterone system inhibitors and beta-blockers on markers of arterial stiffness
- (2013) Charalambos Koumaras et al. Journal of the American Society of Hypertension
- Losartan Added to β-Blockade Therapy for Aortic Root Dilation in Marfan Syndrome: A Randomized, Open-Label Pilot Study
- (2013) Hsin-Hui Chiu et al. MAYO CLINIC PROCEEDINGS
- Effect of antihypertensive therapy on ventricular-arterial mechanics, coupling, and efficiency
- (2012) C. S. P. Lam et al. EUROPEAN HEART JOURNAL
- Effects of atenolol, perindopril and verapamil on haemodynamic and vascular function in Marfan syndrome - a randomised, double-blind, crossover trial
- (2012) Andrew Williams et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- Angiotensin converting enzyme inhibitors effect on arterial stiffness and wave reflections: A meta-analysis and meta-regression of randomised controlled trials
- (2011) Yousef Shahin et al. ATHEROSCLEROSIS
- Aortic stiffness is reduced beyond blood pressure lowering by short-term and long-term antihypertensive treatment: a meta-analysis of individual data in 294 patients
- (2011) Kim-Thanh Ong et al. JOURNAL OF HYPERTENSION
- The Effect of an Angiotensin Receptor Blocker on Arterial Stiffness in Type 2 Diabetes Mellitus Patients with Hypertension
- (2011) Ji Hyun Kim et al. Diabetes & Metabolism Journal
- 2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease
- (2010) et al. CIRCULATION
- Amlodipine-Valsartan Combination Decreases Central Systolic Blood Pressure More Effectively Than the Amlodipine-Atenolol Combination
- (2010) Pierre Boutouyrie et al. HYPERTENSION
- 2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease
- (2010) Loren F. Hiratzka et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Biventricular and atrial diastolic function assessment using conventional echocardiography and tissue-Doppler imaging in adults with Marfan syndrome
- (2009) A. Kiotsekoglou et al. European Journal of Echocardiography
- Effect of Intensive Versus Standard Blood Pressure Lowering on Diastolic Function in Patients With Uncontrolled Hypertension and Diastolic Dysfunction
- (2009) Scott D. Solomon et al. HYPERTENSION
- A comparison of atenolol and nebivolol in isolated systolic hypertension
- (2009) Zahid Dhakam et al. JOURNAL OF HYPERTENSION
- -Blockers Reduce Aortic Stiffness in Hypertension but Nebivolol, Not Atenolol, Reduces Wave Reflection
- (2008) A. Mahmud et al. AMERICAN JOURNAL OF HYPERTENSION
- A randomized, double-blind study of valsartan versus metoprolol on arterial distensibility and endothelial function in essential hypertension
- (2008) M. Kosch et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Angiotensin II Blockade and Aortic-Root Dilation in Marfan's Syndrome
- (2008) Benjamin S. Brooke et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More